Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01975194 · ClinicalTrials.gov registry record · Phase 4
Rosuvastatin in African Americans With Cerebrovascular Disease
A Phase 4 study, sponsored by Wayne State University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01975194 is a Phase 4 study that was terminated before completion, run by Wayne State University. The registered enrollment target is 20 participants.
The verdict
NCT01975194, a Phase 4 study, was terminated before completion, sponsored by Wayne State University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will assess the rate at which rosuvastatin will achieve LDL targets in African American patients with previous history of stroke or TIA.
Interventions
- DRUG Rosuvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01975194
The ClinicalTrials.gov registry entry for NCT01975194 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rosuvastatin is the first listed.
NCT01975194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01975194 about?
NCT01975194 is a clinical study titled "Rosuvastatin in African Americans With Cerebrovascular Disease". This study will assess the rate at which rosuvastatin will achieve LDL targets in African American patients with previous history of stroke or TIA.
What is the current status of trial NCT01975194?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2012-01. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01975194?
The interventions under investigation include: Rosuvastatin (DRUG).
Who is sponsoring clinical trial NCT01975194?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.